RESMED INC (RMD)

US7611521078 - Common Stock

240.51  +2.58 (+1.08%)

After market: 240.51 0 (0%)

Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to RMD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 232.14. This target is -3.48% below the current price.
RMD was analyzed by 19 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about RMD.
In the previous month the buy percentage consensus was at a similar level.
RMD was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 240.51181.80234.60232.14294.00 - -24.41% -2.46% -3.48% 22.24%
Up and Down Grades
Date Firm Action Rating
2024-10-01 Needham Reiterate Hold
2024-10-01 RBC Capital Maintains Sector Perform -> Sector Perform
2024-09-26 B of A Securities Maintains Buy -> Buy
2024-09-24 Baird Initiate Outperform
2024-09-18 Wolfe Research Downgrade Peer Perform -> Underperform
2024-09-18 Needham Reiterate Hold
2024-09-04 Needham Downgrade Buy -> Hold
2024-08-02 Needham Reiterate Buy -> Buy
2024-08-02 Keybanc Maintains Overweight -> Overweight
2024-08-02 RBC Capital Maintains Sector Perform -> Sector Perform
2024-07-23 RBC Capital Maintains Sector Perform -> Sector Perform
2024-06-25 Oppenheimer Downgrade Outperform -> Perform
2024-06-24 Needham Reiterate Buy -> Buy
2024-06-24 Citigroup Downgrade Buy -> Neutral
2024-04-26 Needham Maintains Buy -> Buy
2024-04-26 Keybanc Maintains Overweight -> Overweight
2024-04-26 Oppenheimer Maintains Outperform -> Outperform
2024-04-26 RBC Capital Maintains Sector Perform -> Sector Perform
2024-04-01 Needham Maintains Buy -> Buy
2024-03-27 Mizuho Maintains Buy -> Buy
2024-02-06 Keybanc Initiate Overweight
2024-01-30 Mizuho Maintains Buy -> Buy
2024-01-30 Oppenheimer Maintains Outperform -> Outperform
2024-01-26 Mizuho Maintains Buy -> Buy
2024-01-25 UBS Maintains Neutral -> Neutral
2024-01-25 Needham Maintains Buy -> Buy
2024-01-25 RBC Capital Maintains Sector Perform -> Sector Perform
2024-01-09 JP Morgan Maintains Overweight -> Overweight
2023-10-31 Mizuho Maintains Buy -> Buy
2023-10-27 Morgan Stanley Upgrade Equal-Weight -> Overweight